Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: neurontin attending: chief complaint: dyspnea major surgical or invasive procedure: thoracentesis history of present illness: mrs. is a 75 year old female with a pmh significant for metastatic colon cancer on palliative cetuximab therapy admitted to the micu for dyspnea and hypoxia. the patient reports that she has had progresive shortness of breath over the past 2 weeks such that she was dyspneic with minimal activity inclduing activities such as showering. she denies any orthopnea, pnd, increased le edema, cp, f/c/s, or productive cough. the patient presented to oncology clinic this morning for scheduled cetuximab therapy and was noted to have a sao2 87%ra increased to mid-90s on 3l nc. upon infusion of cetuximab, she developed acute worsening of her dyspnea and was transferred to the ed for further evaluation. . in the ed, vs 95.2 146 132/87 46 94%nrb. an ecg was notable for afib with rvr, cxr for right-sided pleural effusion and diffuse parenchymal opacities, and a large right-sided pleural effusion, and cta was negative for pe. the patient was placed on bipap with subjective improvement and subsequently converted to nsr. attempts to discontinue bipap resulted in marked increase in dyspnea and o2 sat 90%. the patient was also noted to have a tnt of 0.4 up from <0.01 on admission, bnp 700, and lactate 4. cardiology was called in the ed and based on ecg and cardiac biomarkers, elevated tnt was felt to be secondary to demand ischemia but recommended heparin gtt. the patient received asa 325 mg, vancomycin, heparin gtt, and pip/tazo and was transferred to the micu for further management. past medical history: colon ca hypothyroid hyperlipidemia iron deficiency anemia gastritis . oncologic history: metastatic colon cancer, status post five cycles of folfox and avastin on protocol, which was completed in . chemotherapy was resumed in in the setting of rising cea and ct evidence of disease progression. she completed 13 cycles of oxaliplatin, capecitabine, and avastin as of . she had a rise in her cea and therefore her regimen was switched to folfiri and avastin on . infusional 5-fu was reduced by 50% given her history of myelosuppression, diarrhea. her second cycle of therapy, bolus 5-fu was reduced by 25% in the setting of mucositis and vaginal irritation. in total, she completed three cycles of this regimen. chemotherapy was discontinued as of . she had a rise in her cea in addition to interval disease progression at the end of and therefore she was started on single cetuximab and has received 13 doses. kras testing of her original tumor specimen was wild type. social history: patient lives with husband. independent in aidls. former smoker (quit 12 years ago, 1ppd x20 years). denies etoh, iv, illicit, or herbal drug use. family history: father died of colon cancer @about 77. sister died of ovarian cancer @57. mother died of chf @56. daughter died of glioma @20. physical exam: gen: on bipap heent: perrl, eomi, sclerae anicteric. niv mask in place. cv: nl s1+s2 pulm: rhonchorous throughout bilaterally. dullness to percussion at right base way up lung field. abd: s/nt/nd +bs ext: no c/c/e pertinent results: 04:32pm pleural wbc-283* hct,fl-2* polys-35* lymphs-51* monos-13* eos-1* 04:32pm pleural totprot-5.2 glucose-116 ld(ldh)-934 4:32 pm pleural fluid gram stain (final ): no polymorphonuclear leukocytes seen. no microorganisms seen. fluid culture (final ): no growth. anaerobic culture (preliminary): no growth. cta (): no pulmonary embolism. stable large right-sided pleural effusion with slightly more collapse of the right lower lobe. cth (): no acute intracranial path tte (): the left atrium is normal in size. the estimated right atrial pressure is 10-20mmhg. left ventricular wall thicknesses and cavity size are normal. there is severe global left ventricular hypokinesis (lvef < 20 %) with some preservation of the basal inferior and inferolateral walls. the right ventricular cavity is moderately dilated with depressed free wall contractility. the ascending aorta is mildly dilated. the aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. no aortic regurgitation is seen. the mitral valve leaflets are mildly thickened. trivial mitral regurgitation is seen. there is moderate pulmonary artery systolic hypertension. there is a trivial/physiologic pericardial effusion. impression: severe global left ventricular hypokinesis with relative preservation of the basal inferior and inferolateral walls. marked tachycardia. right ventricular dilation and dysfunction. moderate pulmonary hypertension. brief hospital course: mrs. is a 75 year old female with metastatic colon cancer admitted from oncology clinic with sub-acute dyspnea. # respiratory distress: the patient reports that dypsnea has been worsening over the past 2 weeks. on ct chest review, parenchymal disease burden is worse compared to last ct scan performed prior to admission, and right lower lobe is now completely collapsed. dsypnea less likely to be related to cetuximab therapy given dyspnea and hypoxia prior to chemo infusion. respiratory decline unlikely to be pe given negative cta. there was initial concern given tumor burden for malignant pericardial effusion with resulting hypoxia and tachyarrythmia, but ct and tte did not demonstrate significant pericardial effusion. the patient was placed on bipap in the ed and had a persistent bipap requirement during her admission for comfort. she had a diagnostic and therapeutic thoracentesis with exudative pleural fluid based on light's criteria with cytology pending at the time of death. serial cxr after therapeutic paracentesis was performed were notable for reaccumulation of pleural effusion, and attempts at weaning bipap were unsuccessful. after numerous family meetings in discussion with the patient's primary oncologist (dr. and pcp (dr. and the patient and her family, the patient was made comfort measures only. bipap was titrated for comfort and the patient expired shortly thereafter. # narrow complex tachycardia: the patient presented in the ed with atrial fibrillation that spontaneously converted to nsr. during her hospital course, she intermitently had runs of narrow complex tachycardia with a ventricular rate up to 220 that was minimally responsive to av nodal blockade with iv metoprolol and diltiazem. the frequency of the patient's svt increased during her admission such that by the time of her death she had a hr>100 despite po metoprolol. # cv: increase in tnt during admission likely represented demand ischemia rather than acs in setting of tachyarrythmia. bnp was also elevated to 700 on admission suggesting element of heart failure that may have been rate-related. she was initially heparinized per discussion with cardiology, and this was held as the patient was transitioned to comfort measures only. # colon ca: patient with extensive mets on palliative biologic therapy with cetuximab. the patient's primary oncologist was involved in family discussions as the patient was transitioned to cmo. # goals of care: as above, multiple family meetings were held during her admission in consultation with the patient's primary oncologist, pcp, palliative care and the patient was transitioned to comfort measures only. medications on admission: atenolol 50 mg daily diazepam 5 mg q8h prn lomotil 2 tablets q4-6h prn for diarrhea hctz 25 mg daily irbesartan 150 mg daily levothyroxine 200 mcg daily lorazepam 0.5 mg tablet q8h prn for anxiety opium tincture 10 mg/ml 0.3-0.5 ml po q6h prn diarrhea coumadin 1 mg po qhs for venous catheter patency. discharge medications: patient expired discharge disposition: expired discharge diagnosis: patient expired discharge condition: patient expired discharge instructions: patient expired followup instructions: patient expired procedure: thoracentesis diagnoses: subendocardial infarction, initial episode of care unspecified pleural effusion unspecified acquired hypothyroidism atrial fibrillation other chronic pulmonary heart diseases pulmonary collapse other and unspecified hyperlipidemia acute respiratory failure secondary malignant neoplasm of lung tachycardia, unspecified malignant neoplasm of colon, unspecified site 

Answer: The patient is high likely exposed to